Role of delocalized point of care diagnosis of Rickettsioses in Senegal (Africa)  by Sokhna, C.S.
16th ICID Abstracts / International Journal of Infectious Diseases 21S (2014) 1–460 67
second cause of fever in rural areas after malaria. In many other
countries such studies have not yet been conducted. The identiﬁ-
cation of R. felis inmosquitoes questions their role in this disease. In
practice, because of their difﬁculty of diagnosis, rickettsioses were
considered, during the greater part of the 20th century, as rare dis-
eases. In reality, they are among the most commons in travellers
as a cause of fever, as well as in people, worldwide, in contact with
biting arthropods. Finally the current pitfall in this ﬁeld is the mis-
use of nested PCR that generate many false positive diagnosis and
should be avoided.
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A growing range of rapid diagnostic tests can be performed
at the Point-of-Care laboratory (POC) to elucidate the etiology of
febrile conditions. In tropical Africa, the spectrum of the bacterial
pathogens causing fever is poorly understood andmolecular-based
diagnostic laboratories are rare, the time lag between test results
and patient care is a critical point for treatment of disease. This
study provides the activity report of a POC in a rural Senegal vil-
lage, the information for its implementation in ﬁeld conditions and
describes themethodologyused toorganize the runningof this new
biomedical technology in response to the needs of rural African
healthcare. Based on accumulated knowledge of the repertoire of
microbial causes of febrile diseases in rural Senegal, we imple-
mented the rural POC in Dielmo (Senegal) to decrease the time lag
between test results and patient care. From February 2011 to May
2012, 563 blood specimens from febrile patients were collected
in Dielmo and Ndiop villages. All samples were screened for Bor-
relia spp., Coxiella burnetii, Tropheryma whipplei, Rickettsia conorii,
R. africae, R. felis, and Bartonella spp. We identiﬁed DNA from at
least one bacterial pathogen in 120/563 (21.3%) of the samples from
febrile patients. B. crociduraewas identiﬁed in 59 cases (10.5%), and
R. felis in 36 cases (6.4%), Bartonella spp. in 22/563 cases (4%), C. bur-
netii in 2 cases (0.3%) and T. whipplei in one patient (0.2%). R. africae
and R. conorii were not detected. Among 8 co-infected patients, 5
were co-infected by R. felis and B. crocidurae, 2 by B. crocidurae and
Bartonella spp., 1 by B. crocidurae and C. burnetii and 1 by R. felis
and B. quintana in 1. We report the proof of concept of POC in rural
tropical Africa. Diagnosing that 21.3% of acute infections can be
successfully treatedwith doxycycline should change the treatment
strategy for acute fevers in West Africa.
http://dx.doi.org/10.1016/j.ijid.2014.03.562
Type: Invited Presentation
Final Abstract Number: 32.004
Session: Rickettsitosis in Africa
Date: Saturday, April 5, 2014
Time: 10:15-12:15
Room: Room 2.40
Rickettsial disease in febrile patients in Africa
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Can pediatric HIV be eliminated?
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The World Health Organization (WHO) has called for the “vir-
tual elimination” of pediatricHIV. Virtual elimination, an ambitious
program encompasses the goals of reducing the number of new
child HIV infections by 90% by 2015 and to reduce perinatal trans-
mission to rates of less than 5%. To achieve this will require: 1)
efforts to decrease primary HIV infection in young women; 2) the
prevention of unintended pregnancies in HIV infected women; 3)
the reduction of perinatal transmission; 4) optimital care for fam-
ilies infected with HIV. This will require signiﬁcant resources at
a country level aimed at health systems strengthening, especially
in countries with a high burden of HIV. Improving access to con-
traception and universal HIV testing for women of child bearing
potential will be a critical component to achieving this. Ensuring
that all pregnant women attend antenatal care, receiving regular
HIV testing during pregnancy and timely triage into antiretrovi-
ral care without seepage will help to drive perinatal transmission
down. Preventing post-natal transmission through breastfeeding
and retention in care of both mother and infant are critical. This
talkwill look at the barriers and challenges to eliminating pediatric
HIV as well as looking at strategies for potential pediatric cure.
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